Aradigm Ends Effort to Win EU Approval for Linhaliq in Treating NCFBE Chronic Lung Infections
News
Aradigm has withdrawn its application to the European Medicines Agency (EMA) requesting approval of Linhaliq for the treatment and prevention of flares in non-cystic fibrosis bronchiectasis patients with chronic lung infections linked to Pseudomonas ... Read more